MedPath

Tampere University

Tampere University logo
🇫🇮Finland
Ownership
Private
Established
1965-08-13
Employees
1K
Market Cap
-
Website
http://www.tuni.fi

Allergy, Asthma, and Atopic Eczema in Finland

Not yet recruiting
Conditions
Rhinitis, Allergic
Atopic Dermatitis
Asthma
Asthma in Children
Allergy
Allergen Immunotherapy
First Posted Date
2024-03-26
Last Posted Date
2024-03-26
Lead Sponsor
Tampere University
Target Recruit Count
2000000
Registration Number
NCT06330974
Locations
🇫🇮

Tampere University, Tampere, Finland

Dialogical Family Guidance PostDoc Study

Not Applicable
Recruiting
Conditions
Family Dynamics
Family Support
Family Relations
Interventions
Behavioral: Dialogical Family Guidance (DFG)
First Posted Date
2024-03-21
Last Posted Date
2024-03-21
Lead Sponsor
Tampere University
Target Recruit Count
50
Registration Number
NCT06322511
Locations
🇫🇮

Helsinki university hospital, Helsinki, Finland

Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency

Not Applicable
Recruiting
Conditions
Ventilation Therapy
Chronic Respiratory Failure
ALS
Interventions
Other: NIV initiation in patients with ALS
First Posted Date
2024-02-29
Last Posted Date
2024-03-22
Lead Sponsor
Tampere University
Target Recruit Count
120
Registration Number
NCT06286917
Locations
🇫🇮

Tampere University Hospital, Tampere, Finland

Multimodal Noninvasive Assessment of Peripheral Circulation in Chronic Limb-threatening Ischemia

Recruiting
Conditions
Chronic Limb Threatening Ischemia
First Posted Date
2023-03-27
Last Posted Date
2024-06-20
Lead Sponsor
Tampere University
Target Recruit Count
150
Registration Number
NCT05786001
Locations
🇫🇮

Tampere University, Tampere, Pirkanmaa, Finland

The MOTIVE (Multiparas Overcoming Childbirth Fear Through Intervention and Empowerement) Feasibility Trial

Not Applicable
Completed
Conditions
Anxiety
Depression
Fear of Childbirth
Interventions
Other: An group intervention for multiparas with fear of childbirth
First Posted Date
2023-03-13
Last Posted Date
2024-06-11
Lead Sponsor
Tampere University
Target Recruit Count
19
Registration Number
NCT05766202
Locations
🇫🇮

Kanta-Hämeen Keskussairaala, Hämeenlinna, Finland

The Effect of Mindfulness-based Cognitive Behavior Therapy on Occupational Stress Management

Not Applicable
Completed
Conditions
Occupational Stress
Interventions
Behavioral: Cognitive behavior therapy (CBT) and Mindfulness-based stress reduction (MBSR) programs
First Posted Date
2022-11-23
Last Posted Date
2024-05-14
Lead Sponsor
Tampere University
Target Recruit Count
218
Registration Number
NCT05626543
Locations
🇫🇮

Tampere University, Tampere, Pirkanmaa, Finland

Vitamin D Supplementation for the Prevention of Acute Respiratory Infections: a RCT in Young Finnish Men

Not Applicable
Completed
Conditions
Vitamin D Deficiency
Respiratory Tract Infections
Interventions
Dietary Supplement: Vitamin D3
Dietary Supplement: Placebo
First Posted Date
2021-08-20
Last Posted Date
2023-10-18
Lead Sponsor
Tampere University
Target Recruit Count
231
Registration Number
NCT05014048
Locations
🇫🇮

Finnish Defence Forces, Hämeenlinna, Finland

Supporting New Graduated Nurse's Professional Competence, a Theoretical Model for Optimal Orientation

Not Applicable
Completed
Conditions
Competence
Nurse's Role
Interventions
Other: Educational intervention for preceptors
First Posted Date
2020-07-17
Last Posted Date
2020-07-17
Lead Sponsor
Tampere University
Target Recruit Count
114
Registration Number
NCT04474769

Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients With High Risk Stable CHD

Not Applicable
Recruiting
Conditions
Coronary Heart Disease
Interventions
Behavioral: personalised prevention program (PPP)
First Posted Date
2020-06-16
Last Posted Date
2023-06-12
Lead Sponsor
Tampere University
Target Recruit Count
12000
Registration Number
NCT04433052
Locations
🇫🇮

Helsinki University Hospital, Helsinki, Finland

🇫🇮

Kuopio University Hospital, Kuopio, Finland

🇩🇪

CCV-MVZ, Frankfurt, Germany

and more 23 locations

Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in Mali

Phase 3
Active, not recruiting
Conditions
Mortality
Interventions
Drug: Placebo
Drug: Azithromycin
First Posted Date
2020-06-11
Last Posted Date
2024-12-12
Lead Sponsor
Tampere University
Target Recruit Count
100000
Registration Number
NCT04424511
Locations
🇲🇱

Center for Vaccine Development CVD-Mali, Bamako, Mali

© Copyright 2025. All Rights Reserved by MedPath